Cargando…

Acute Kidney Injury Caused by Renin-Angiotensin System Inhibitors During Minimal Change Disease Treatment

A 76-year-old Japanese man with nephrotic syndrome was admitted to our department for treatment. After his admission, he was administered prednisolone (PSL) at 40 mg/day, and a percutaneous renal biopsy was performed. However, on the first day of admission, his urinary protein decreased from 5.05 g/...

Descripción completa

Detalles Bibliográficos
Autores principales: Torigoe, Kenta, Ikemi, Yuta, Yoshida, Yuki, Sakamoto, Ryosuke, Yamashita, Ayuko, Abe, Shinichi, Muta, Kumiko, Arai, Hideyuki, Mukae, Hiroshi, Nishino, Tomoya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9665908/
https://www.ncbi.nlm.nih.gov/pubmed/36407214
http://dx.doi.org/10.7759/cureus.30346
_version_ 1784831388333113344
author Torigoe, Kenta
Ikemi, Yuta
Yoshida, Yuki
Sakamoto, Ryosuke
Yamashita, Ayuko
Abe, Shinichi
Muta, Kumiko
Arai, Hideyuki
Mukae, Hiroshi
Nishino, Tomoya
author_facet Torigoe, Kenta
Ikemi, Yuta
Yoshida, Yuki
Sakamoto, Ryosuke
Yamashita, Ayuko
Abe, Shinichi
Muta, Kumiko
Arai, Hideyuki
Mukae, Hiroshi
Nishino, Tomoya
author_sort Torigoe, Kenta
collection PubMed
description A 76-year-old Japanese man with nephrotic syndrome was admitted to our department for treatment. After his admission, he was administered prednisolone (PSL) at 40 mg/day, and a percutaneous renal biopsy was performed. However, on the first day of admission, his urinary protein decreased from 5.05 g/gCr to 1.85 g/gCr. On the fourth day of admission, his urinary protein further decreased to 0.38 g/gCr and the patient developed acute kidney injury (AKI). Renin-angiotensin system (RAS) inhibitors were suspected to be the cause of AKI; therefore, they were discontinued. After the renal function improved, the urinary protein worsened again to 5.49 g/gCr. Renal pathology suggested minimal change disease (MCD); therefore, PSL was continued. The patient’s urinary protein subsequently improved and he had no renal function impairment. Minimal change disease can be complicated by AKI through intravascular volume depletion caused by high urinary protein and hypoalbuminemia. However, when MCD is complicated by RAS inhibitor-associated AKI, the urinary protein may notably decrease, and the patient may present with an atypical course of MCD-associated AKI.
format Online
Article
Text
id pubmed-9665908
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Cureus
record_format MEDLINE/PubMed
spelling pubmed-96659082022-11-17 Acute Kidney Injury Caused by Renin-Angiotensin System Inhibitors During Minimal Change Disease Treatment Torigoe, Kenta Ikemi, Yuta Yoshida, Yuki Sakamoto, Ryosuke Yamashita, Ayuko Abe, Shinichi Muta, Kumiko Arai, Hideyuki Mukae, Hiroshi Nishino, Tomoya Cureus Nephrology A 76-year-old Japanese man with nephrotic syndrome was admitted to our department for treatment. After his admission, he was administered prednisolone (PSL) at 40 mg/day, and a percutaneous renal biopsy was performed. However, on the first day of admission, his urinary protein decreased from 5.05 g/gCr to 1.85 g/gCr. On the fourth day of admission, his urinary protein further decreased to 0.38 g/gCr and the patient developed acute kidney injury (AKI). Renin-angiotensin system (RAS) inhibitors were suspected to be the cause of AKI; therefore, they were discontinued. After the renal function improved, the urinary protein worsened again to 5.49 g/gCr. Renal pathology suggested minimal change disease (MCD); therefore, PSL was continued. The patient’s urinary protein subsequently improved and he had no renal function impairment. Minimal change disease can be complicated by AKI through intravascular volume depletion caused by high urinary protein and hypoalbuminemia. However, when MCD is complicated by RAS inhibitor-associated AKI, the urinary protein may notably decrease, and the patient may present with an atypical course of MCD-associated AKI. Cureus 2022-10-16 /pmc/articles/PMC9665908/ /pubmed/36407214 http://dx.doi.org/10.7759/cureus.30346 Text en Copyright © 2022, Torigoe et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Nephrology
Torigoe, Kenta
Ikemi, Yuta
Yoshida, Yuki
Sakamoto, Ryosuke
Yamashita, Ayuko
Abe, Shinichi
Muta, Kumiko
Arai, Hideyuki
Mukae, Hiroshi
Nishino, Tomoya
Acute Kidney Injury Caused by Renin-Angiotensin System Inhibitors During Minimal Change Disease Treatment
title Acute Kidney Injury Caused by Renin-Angiotensin System Inhibitors During Minimal Change Disease Treatment
title_full Acute Kidney Injury Caused by Renin-Angiotensin System Inhibitors During Minimal Change Disease Treatment
title_fullStr Acute Kidney Injury Caused by Renin-Angiotensin System Inhibitors During Minimal Change Disease Treatment
title_full_unstemmed Acute Kidney Injury Caused by Renin-Angiotensin System Inhibitors During Minimal Change Disease Treatment
title_short Acute Kidney Injury Caused by Renin-Angiotensin System Inhibitors During Minimal Change Disease Treatment
title_sort acute kidney injury caused by renin-angiotensin system inhibitors during minimal change disease treatment
topic Nephrology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9665908/
https://www.ncbi.nlm.nih.gov/pubmed/36407214
http://dx.doi.org/10.7759/cureus.30346
work_keys_str_mv AT torigoekenta acutekidneyinjurycausedbyreninangiotensinsysteminhibitorsduringminimalchangediseasetreatment
AT ikemiyuta acutekidneyinjurycausedbyreninangiotensinsysteminhibitorsduringminimalchangediseasetreatment
AT yoshidayuki acutekidneyinjurycausedbyreninangiotensinsysteminhibitorsduringminimalchangediseasetreatment
AT sakamotoryosuke acutekidneyinjurycausedbyreninangiotensinsysteminhibitorsduringminimalchangediseasetreatment
AT yamashitaayuko acutekidneyinjurycausedbyreninangiotensinsysteminhibitorsduringminimalchangediseasetreatment
AT abeshinichi acutekidneyinjurycausedbyreninangiotensinsysteminhibitorsduringminimalchangediseasetreatment
AT mutakumiko acutekidneyinjurycausedbyreninangiotensinsysteminhibitorsduringminimalchangediseasetreatment
AT araihideyuki acutekidneyinjurycausedbyreninangiotensinsysteminhibitorsduringminimalchangediseasetreatment
AT mukaehiroshi acutekidneyinjurycausedbyreninangiotensinsysteminhibitorsduringminimalchangediseasetreatment
AT nishinotomoya acutekidneyinjurycausedbyreninangiotensinsysteminhibitorsduringminimalchangediseasetreatment